October 1, 2019
Sixth time's the charm? Roche’s Accu-Chek Connect Diabetes Management App has notched its sixth device recall from the FDA, this time due to meter-to-app data transfer issues for users with Android OS 8.0 and above. According to the agency’s posting, Roche notified partners, users and call centers of the issue and released and update addressing the problem before the end of that month.
September 18, 2019
This morning Google announced that the health team at DeepMind, an artificial intelligence Alphabet subsidiary primarily focused on research, is joining Google Health.
“Under the leadership of Dr. David Feinberg, and alongside other teams at Google, we’ll now be able to tap into global expertise in areas like app development, data security, cloud storage and user-centered design to build...
September 5, 2019
Alphabet’s life science branch Verily is teaming up with digital health startup iRhythm on a new initiative focused on creating screening, diagnosis and management tools for patients with atrial fibrillation.
The collaboration is specifically targeted at alerting patients with asymptomatic or silent atrial fibrillation about their condition. The goal is to develop products that not only identify...
August 7, 2019
Nearly five years after Alphabet purchased DeepMind, an AI-focused technology entity, it is still continuing to report massive losses on the subsidiary. Yesterday DeepMind released its latest strategic report, revealing that its losses for the financial year were £470 million, or roughly $571 million.
Deep Mind has been heavily involved in the healthcare space, using its AI platform for diagnosis...
February 4, 2019
A Google patent application published on Thursday by the US Patent and Trademark Office gives a few more details on a predictive EHR system first highlighted by the tech company last May. The application was filed by Google in July 2017, and has not yet been granted.
As described in the application, Google’s system can aggregate and store EHRs for a diverse population, while compiling each...
January 18, 2019
This morning Alphabet’s life science subsidiary Verily announced that its Verily Study Watch and its on-demand ECG feature landed a 510(k) clearance from the FDA.
The watch is a prescription-only device, and was designed to record, store, transfer and display single-channel ECG rhythms. The company said the device’s ability to take on-demand, single-lead ECG can be used for individual patient...
January 4, 2019
This morning Alphabet life science subsidiary Verily announced a staggering $1 billion in new venture funding led by Silver Lake, with participation from Ontario Teacher’s Pension Plan and other global investment management firms. As part of the deal, Silver Lake Managing Partner and Director Egon Durban will be nominated to the company’s operating board, as will Ruth Porat, chief financial...
January 3, 2019
Just in time for those New Year’s resolutions, Lifesum, a Swedish health tracking app, will now be available to Google Assistant users. This integration will allow users to keep a record of their meals, water consumption and weight by talking to their Google Assistant.
Users can access the system by saying “Hey Google, talk to Lifesum,” according to a press release. Once opened the user can tell...
December 20, 2018
Alphabet’s business interests cover a wide range of industries, and healthcare is certainly among them. With each passing year, Alphabet (or Google, or Verily) unveils a growing collection of tech-driven partnerships and healthcare tools — read on for a compilation of the company’s news in 2018.
January 4: Cityblock Health, the urban-focused public health startup that spun out of Alphabet’s...
November 16, 2018
Four years after announcing an ambitious — and often ridiculed — project to create a glucose-sensing contact lens along with Novartis subsidiary Alcon, Alphabet's Verily is throwing in the towel, the company announced in a blog post today. It will continue to work on two other medical contact lens projects, aimed at presbyopia and cataract surgery recovery.
"Our clinical work on the glucose-...